Headshot of Anthony Zador.

Anthony Zador

Professor of biology, Cold Spring Harbor Laboratory;
Contributing editor, The Transmitter

Anthony Zador is Alle Davis Harris Professor of Biology at Cold Spring Harbor Laboratory in New York. The goal of his research is to understand the neural circuits underlying sensorimotor decision-making. His laboratory pioneered the use of rodents in complex decision-making tasks and developed a novel suite of approaches, including MAPseq and BARseq, for determining brain wiring using high-throughput DNA sequencing. His current research interests include neuroscience-inspired artificial intelligence. He is the co-founder of several meetings, including Computational and Systems Neuroscience and From Neuroscience to Artificially Intelligent Systems.

Zador received his M.D. and Ph.D. from Yale University and did postdoctoral work at the Salk Institute for Biological Studies in La Jolla, California, before joining the faculty at Cold Spring Harbor Laboratory.

Explore more from The Transmitter

Grid of human brain scans.

Dose, scan, repeat: Tracking the neurological effects of oral contraceptives

We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.

By Carina Heller
20 January 2025 | 7 min read
Colorful illustration of a latticework of proteins.

Cracking the code of the extracellular matrix

Despite evidence for a role in plasticity and other crucial functions, many neuroscientists still view these proteins as “brain goop.” The field needs technical advances and a shift in scientific thinking to move beyond this outdated perspective.

By Anna Victoria Molofsky
17 January 2025 | 5 min read
A repeated DNA strand extends farther from the left side of the image with each iteration.

Huntington’s disease gene variants past a certain size poison select cells

The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.

By Angie Voyles Askham
16 January 2025 | 6 min read